7Baggers
Quarterly
Annual
    Unit: USD2025-09-28 2025-06-29 2025-03-30 2024-12-29 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-03-27 2021-12-26 2021-09-26 2020-06-28 2019-06-30 2019-03-31 2018-12-30 2018-09-30 2018-07-01 2018-04-01 2017-12-31 2017-10-01 2016-10-02 2016-03-27 2013-06-30 2013-03-31 2012-12-30 2012-09-30 2012-04-01 2012-01-01 2011-10-02 
      
    		                                   
      operating activities:
    		                                   
      net income
    		-52,957,000 -51,907,000 -178,244,000 64,348,000 -34,190,000 -20,867,000 -16,903,000 62,907,000 -31,242,000 -22,547,000 -70,993,000 82,530,000 -33,692,000 -22,250,000 -23,409,000 88,468,000 -13,199,000 9,774,000 -8,305,000 -8,241,000 68,578,000 -17,266,000 -8,223,000 -8,463,000 70,699,000 -13,222,000 -15,771,000 -9,126,000 -1,722,000 2,638,000 16,011,000 -4,606,000 -84,000 16,638,000 -740,000 
      reconciliation of net income to net cash from operating activities, net of acquisitions:
    		                                   
      depreciation and amortization
    		12,902,000 13,331,000 13,119,000 14,130,000 13,038,000 13,174,000 13,232,000 14,152,000 13,194,000 13,397,000 13,267,000 14,315,000 12,694,000 12,827,000 12,693,000 12,588,000 10,970,000 9,245,000 7,125,000 7,028,000 7,969,000 7,843,000 7,823,000 7,885,000 8,677,000 8,084,000 7,997,000 7,546,000 4,959,000 4,850,000 4,531,000 4,458,000 4,874,000 4,929,000 4,902,000 
      amortization of deferred financing costs
    		177,000 305,000 200,000 181,000 180,000 183,000 180,000 181,000 180,000 836,000 327,000 326,000 345,000 326,000 327,000 317,000 299,000 160,000 298,000 219,000 228,000 224,000 232,000 241,000 240,000 240,000 374,000 392,000 77,000 114,000 115,000 114,000 114,000 115,000 114,000 
      deferred income taxes
    		-232,000 -2,304,000 -8,923,000 -889,000 -607,000 -3,197,000 -2,427,000 -5,529,000 -579,000 -218,000 -3,544,000 -465,000 -381,000 3,257,000 -372,000 -565,000 -741,000 1,331,000 1,887,000 1,465,000 -395,000 -259,000 5,336,000 -666,000 -11,952,000 -386,000 -703,000 -266,000       963,000 
      bad debt expense
    		4,000 230,000 313,000 47,000 84,000 -167,000 193,000 -361,000 586,000 994,000 590,000 2,142,000 265,000 462,000 412,000 -1,189,000 -96,000 2,942,000 365,000 436,000 358,000 224,000 162,000 488,000 218,000 200,000 188,000 332,000 323,000 285,000 213,000 264,000 365,000 100,000 227,000 
      stock-based compensation
    		2,312,000 2,785,000 2,998,000 3,629,000 2,479,000 3,047,000 3,046,000 2,231,000 2,364,000 2,393,000 2,487,000 1,899,000 1,555,000 1,144,000 1,507,000 2,291,000 3,005,000 1,993,000 1,779,000 1,903,000 1,673,000 955,000 724,000 933,000 968,000 1,101,000 1,774,000 1,650,000 886,000 1,093,000 1,315,000 989,000 1,356,000 1,211,000 1,169,000 
      other non-cash items
    		232,000 2,174,000 251,000 -667,000 255,000 432,000 263,000 -655,000 270,000 340,000 225,000 -796,000 326,000 1,842,000 1,800,000 -708,000 260,000 1,055,000 285,000 200,000 -787,000 286,000 316,000 352,000 -342,000 239,000 264,000 118,000 270,000 0 208,000 5,000  39,000 58,000 
      changes in operating items, net of acquisitions:
    		                                   
      trade receivables
    		-15,072,000 6,849,000 32,267,000 -20,375,000 -23,025,000 8,921,000 19,606,000 -1,977,000 -24,407,000 15,380,000 15,645,000 -6,206,000 -25,416,000 16,118,000 36,504,000 -45,366,000 -9,708,000 8,097,000 6,427,000 28,798,000 -18,023,000 -18,024,000 9,417,000 21,422,000 -8,932,000 -21,837,000 -23,886,000 47,567,000        
      inventories
    		-92,654,000 -16,813,000 -2,877,000 117,885,000 -97,439,000 -17,102,000 1,866,000 119,095,000 -89,287,000 560,000 10,525,000 141,544,000 -95,038,000 -33,119,000 -23,394,000 100,043,000 -128,577,000 -23,724,000 -17,984,000 -10,371,000 96,674,000 -71,855,000 -19,919,000 -8,339,000 87,853,000 -72,558,000 -88,054,000 -222,000        
      prepaid and other
    		-3,252,000 -7,351,000 -4,181,000 35,087,000 -29,237,000 -1,848,000 -1,879,000 21,404,000 -14,764,000 9,848,000 -4,844,000 26,975,000 -19,425,000 -443,000 -998,000 25,024,000 -16,852,000 -3,874,000 -4,988,000 -484,000 5,890,000 -2,731,000 -6,241,000 4,227,000 4,935,000 -9,207,000 -11,470,000 -1,416,000  -1,594,000   497,000   
      accounts payable and accrued expenses
    		9,461,000 21,949,000 -143,617,000 113,477,000 -8,806,000 12,481,000 -131,481,000 125,446,000 -42,000 21,183,000 -148,856,000 77,308,000 11,742,000 -13,442,000 -153,612,000 158,044,000 2,415,000 12,917,000 -5,895,000 -63,620,000 87,127,000 -8,766,000 3,796,000 -67,816,000 84,307,000 -15,038,000 -5,518,000 -79,837,000 -3,326,000 -11,993,000   -13,725,000   
      other assets and liabilities
    		105,000  -127,000 1,695,000 27,000  1,595,000 -12,000 -157,000  -11,000 411,000 702,000  1,422,000 -2,935,000 2,060,000                   
      net cash from operating activities
    		-138,974,000 -27,069,000 -150,601,000 328,548,000 -177,241,000 -5,052,000 -112,709,000 356,644,000 -143,884,000 42,287,000 -120,596,000 339,983,000 -146,323,000 -33,539,000 -147,120,000 336,012,000 -150,164,000 22,075,000 -18,905,000 -42,578,000 249,006,000 -109,423,000 -6,232,000 -49,593,000 236,468,000 -122,302,000 -134,842,000 -34,626,000 7,910,000 5,596,000   3,047,000   
      investing activities:
    		                                   
      acquisitions, net of cash acquired
    		 0 0 0 -3,000,000     -1,151,000    825,000 -1,319,000   0                  
      capital expenditures
    		-6,652,000 -9,032,000 -9,408,000 -10,948,000 -12,075,000 -12,150,000 -8,675,000 -10,833,000 -6,974,000                           
      free cash flows
    		-145,626,000 -36,101,000 -160,009,000 317,600,000 -189,316,000 -17,202,000 -121,384,000 345,811,000 -150,858,000                           
      net cash from investing activities
    		-6,652,000 -9,032,000 -9,408,000 -10,948,000 -15,075,000 -15,822,000 -8,675,000 -10,833,000 -6,974,000 -14,478,000 -12,502,000 -12,816,000 -11,033,000 -19,638,000 -16,656,000 -42,272,000 -11,122,000 -12,421,000 -15,715,000 -5,059,000 -6,879,000 -4,907,000 -17,497,000 -6,945,000 -4,830,000 -12,534,000 -4,703,000 -6,970,000       3,019,000 
      financing activities:
    		                                   
      acquisition of treasury stock
    		-129,000 -262,000 -2,230,000 -6,428,000 -1,255,000 -1,216,000 -4,391,000 -4,713,000 -74,000 -42,000 -22,000   -3,383,000 -9,267,000 -16,456,000 -9,065,000 -13,000 -1,000 -1,360,000 -9,365,000 -4,040,000 -101,000 -990,000 -6,765,000 -4,320,000 -2,964,000 -1,726,000        
      proceeds from exercise of employee stock options
    		 0 99,000 141,000 41,000 71,000 214,000       0 0 283,000 563,000 0 307,000 564,000 63,000 302,000 158,000 164,000   1,000 137,000 468,000 -16,000 71,000 12,000    
      proceeds from bank borrowings
    		110,000,000 0 0 65,000,000 45,000,000 0 0 47,000,000 35,000,000 200,000,000 0 55,900,000 140,000,000 0 0   0 2,250,000 0   0 0   125,000,000 0 15,000,000 0 10,000,000 37,000,000 0 16,000,000 40,000,000 
      repayment of bank borrowings
    		-3,000,000 0 0 -137,500,000 -2,500,000 -2,500,000 -2,500,000 -84,500,000 -2,500,000           -2,875,000    -2,156,000            
      net cash from financing activities
    		106,871,000 -2,081,000 -2,527,000 -78,787,000 41,286,000 -3,645,000 -6,677,000 -42,169,000 32,426,000 47,400,000 -5,022,000 -146,891,000 135,333,000 -8,383,000 -14,267,000 -26,457,000 -8,502,000 -1,263,000 1,166,000 -3,671,000 -11,458,000 -5,894,000 -2,100,000 -2,982,000 -8,188,000 -5,757,000 118,474,000 -5,152,000    32,306,000   33,752,000 
      net change in cash and cash equivalents
    		-38,755,000 -38,182,000 -162,536,000 238,813,000 -151,030,000 -24,519,000 -128,061,000 303,642,000 -118,432,000 75,209,000 -138,120,000 180,276,000 -22,023,000 -61,560,000 -178,043,000 267,283,000 -169,788,000 8,391,000 -33,454,000 -51,308,000 230,669,000 -120,224,000 -25,829,000 -59,520,000 223,450,000 -140,593,000 -21,071,000 -46,748,000        
      cash and cash equivalents:
    		                                   
      beginning of period
    		46,502,000  0 0 159,437,000  0 0 126,807,000  0 0 31,465,000  0 0 173,573,000   0 0 147,240,000  0 0 149,732,000 27,826,000   0 0 28,854,000 0 0 21,442,000 
      end of period
    		7,747,000  -162,536,000 238,813,000 8,407,000  -128,061,000 303,642,000 8,375,000  -138,120,000 180,276,000 9,442,000  -178,043,000 267,283,000 3,785,000   -51,308,000 230,669,000 27,016,000  -59,520,000 223,450,000 9,139,000 6,755,000 -46,748,000  -9,960,000 21,135,000 5,829,000 -5,202,000 24,371,000 5,707,000 
      goodwill and intangible impairment
    		 5,603,000    0                              
      other assets and other liabilities
    		                                   
      purchase of equity investments
    		                 0                  
      debt issuance costs
    		                                   
      beginning of year
    		                                   
      end of year
    		                                   
      changes in operating items:
    		                                   
      debt issuance cost
    		          0 -716,000 333,000  0                     
      reconciliation of net income to net provided by operating activities, net of acquisitions:
    		                                   
      intangible impairment
    		                                   
      reconciliation of net income to net cash from operating activities net of acquisitions:
    		                                   
      adjustments to reconcile net income to net cash from operating activities:
    		                                   
      goodwill and intangible asset impairment
    		         0                          
      capital expenditures, net of non-cash expenditures
    		         -13,295,000 -7,502,000 -12,816,000 -11,033,000 -18,463,000 -15,337,000 -21,486,000 -11,122,000 -12,421,000 -15,715,000 -5,059,000 -6,879,000 -4,907,000 -17,497,000 -6,945,000 -4,830,000 -4,034,000 -4,703,000 -6,970,000        
      repayment of notes payable and bank borrowings
    		         -150,000,000 -5,000,000 -200,900,000 -5,000,000 -5,000,000 -5,000,000   -1,250,000    -2,156,000    -1,437,000 -3,563,000 -3,561,000        
      adjustments to reconcile net income to net cash provided by operating activities:
    		                                   
      reconciliation of net income to net cash from operating activities net of dispositions:
    		                                   
      working capital adjustment related to sale of fannie may
    		                                   
      reconciliation of net income to net cash from operating activities, net of acquisitions/dispositions:
    		                                   
      gain on sale of fannie may
    		                                   
      other assets
    		                  5,000 61,000 -409,000 -1,000 0 9,000 -83,000 -14,000  59,000     -1,168,000   
      other liabilities
    		                  96,000 28,000 123,000 -53,000 345,000 134,000 -120,000 96,000 -37,000 481,000 -199,000   351,000 1,171,000   
      proceeds from sale of business
    		                                0 816,000 12,010,000 
      reconciliation of net income to net cash from operating activities:
    		                                   
      working capital adjustment related to sale of business
    		                       0 0 -8,500,000          
      foreign equity investment impairment
    		                                   
      loss on sale/impairment of iflorist
    		                                   
      excess tax benefit from stock-based compensation
    		                                   
      insurance receivable
    		                           -1,887,000        
      excess tax benefit from stock based compensation
    		                                   
      non-cash impact of write-offs related to warehouse fire
    		                                   
      other
    		                            95,000 -12,000 -5,000 39,000   29,000 
      foreign equity method investment impairment
    		                           0        
      impairment of iflorist
    		                                   
      fire related gain
    		                                   
      acquisition transaction costs
    		                                   
      loss on sale/assets held for sale impairment-iflorist
    		                                   
      insurance proceeds for warehouse fire related to property damage
    		                                   
      operating activities
    		                                   
      operating activities of discontinued operations
    		                                815,000   
      receivables
    		                                   
      investing activities
    		                                   
      purchase of investments
    		                                   
      investing activities of discontinued operations
    		                                   
      financing activities
    		                                   
      repayment of capital leases
    		                                   
      loss/(gain) on sale of discontinued operations
    		                                   
      changes in operating items, excluding the effects of acquisitions:
    		                                   
      repayment of capital lease obligations
    		                                   
      reconciliation of net income to net cash from operations
    		                                   
      gain on sale of discontinued operations
    		                                   
      purchase of investment
    		                                   
      net change in cash and equivalents
    		                                -5,202,000   
      cash and equivalents:
    		                                   
      numerator:
    		                                   
      income from continuing operations
    		                             -13,373,000      
      denominator:
    		                                   
      weighted-average shares outstanding
    		                             -568,000      
      effect of dilutive securities:
    		                                   
      employee stock options
    		                             288,000      
      employee restricted stock awards
    		                             -166,000      
      adjusted weighted-average shares and assumed conversions
    		                             -446,000      
      net income per common share from continuing operations
    		                                   
      basic
    		                             -210      
      diluted
    		                             -200      
      stock options
    		                               106,000    
      restricted stock awards
    		                               883,000    
      total
    		                               989,000    
      deferred income tax benefit *
    		                               10,000    
      stock-based compensation expense
    		                               999,000    
      deferred taxes
    		                                -312,000   
      change in fair value of cash flow hedge, net of tax
    		                                -13,000 -28,000 73,000 
      comprehensive income
    		                                -16,737,000   
      income from discontinued operations
    		                                   
      operating activities of discontinued operation
    		                                  1,390,000 
      income from sale of store
    		                                  219,000 
      comprehensive loss
    		                                  -667,000 
      loss/impairment from discontinued operations
    		                                   
      goodwill and intangible asset impairment from continuing operations
    		                                   
      stock compensation expense
    		                                   
      financing activities of discontinued operations
    		                                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.